Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive
|
|
- Alberta Cameron
- 5 years ago
- Views:
Transcription
1 Opportunities and Challenges in Pharmaceutical Sciences Helen Gordon Chief Executive
2 Challenges we face
3 Drivers for Change in Health Care... and science too Desire for high quality, safe services. The need for cost effectiveness not just efficiencies The need for fast adoption and diffusion of innovation Changing demography, long term conditions time bomb Complexity of therapy New technologies The need for a flexible and adaptable workforce Balancing national and local Focus on outcomes
4 Cross Sector Change Working in Partnership Challenges Innovations Efficiencies Effectiveness
5 Changes in Workforce Development LETBs Health Education England Levy and Tariff
6 All about adopting and spreading innovation Science, health and education working closely together Pharmaceutical science is core Growing the economy through innovation
7 Quality Innovation Education and Development Effectiveness Delivery
8 Pharmaceutical Science - meeting the challenges - making the most of opportunities
9 Pharmaceutical Science - Crucial to Patient Care Formulations Solubility Patency of veins, running more than 1 drug into a line at the same time Managed entry of new drugs Palatability and formulations
10 Directions of Travel in Healthcare Do elements of this this resonate with you as well? Clinical Leadership and ownership that delivers: Quality improvement Best outcomes for patients Best use of resources Planning and designing integrated care pathways Strategies for service planning, research and health improvement Leadership and engagement Working collaboratively across systems Patient/User involvement, not just engagement
11 Royal Colleges Role - Support and Influence Professional Support. Professional Development & Advancement Leadership and advocacy Science and Research Professional Recognition Professional Standards
12 RPS working for Pharmacists and Pharmaceutical Scientists We work with our partners, such as APS, to ensure: SCIENCE is heard and understood, championed and valued Our partner s voices are heard and promoted in the development and delivery of healthcare policy and medicines expertise Their contribution to patient and public health is recognised and acknowledged They are positioned and trusted as the experts in medicines They are recognised as valued partners with the NHS, the science community, UKPLC and wider society. RPS recognition scheme coming soon.
13 High Media Presence
14 In Summary RPS and APS collaborate to: Ensure that pharmaceutical science is recognised as integral to patient care and wellbeing of the public. Spell out where pharmacy and pharmaceutical science add value, and how the professional bodies aid in this process. Create space for leaders to consider innovation and its spread. Ensure pharmaceutical science is embedded in educational change for pharmacists. Support changes to develop flexible and adaptable workforces in industry, healthcare, academia and research. As individuals, we: Make local connections that support advancement and change. Build partnerships at a national and local level will help patient care and business. Be passionate about developments and opportunities.
15 Thank you
16 RPS Science Award Presented by Helen Gordon Chief Executive
17 RPS Science Award Dr Khuloud Al-Jamal, King s College London
Innovation & health connected. Business plan summary
Innovation & health connected Business plan summary 2017-18 CONTENTS Contents Introduction What do we do? Our five goals Goal 1: Transformation through innovation Goal 2: Economic growth Goal 3: Adoption
More informationEmpowering young people. headspace Strategic Plan
Empowering young people 1. headspace Strategic Plan 2010-2012 Vision To improve the mental and social wellbeing of young Australians through the provision of high quality early intervention services, that
More informationNHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY
NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY 2014-16 Ref Number: Version 3.0 Status FINAL DRAFT Author Oliver Cruickshank Approval body Governing Body Date Approved
More informationHelping your business grow in the UK health system
Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain
More informationNHS Next Stage Review: Innovation
NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused
More informationINNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013
INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 The Challenge Our ambition must be for an NHS defined by its commitment
More informationDigital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver
Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital
More informationDigital Health Strategy
Digital Health Strategy i3 Digital Health Strategy Digital health requires a change in mindset Purpose Drive a change in mindset towards engagement online Goal Exceptional and safe online behaviour and
More informationIndustrial Strategy Green Paper Response from The Institute of Cancer Research, London
Industrial Strategy Green Paper Response from The Institute of Cancer Research, London March 2017 The Institute of Cancer Research (ICR) is one of the world s most influential cancer research organisations
More informationCultural Evolution Is the future in our own hands?
Cultural Evolution Is the future in our own hands? Dr Paul Litchfield - Chief Medical Officer, BT Group Laura Collins - Carer and East Belfast ICP member Colette Goldrick - NI Director, APBI Dr Anne Kilgallen
More informationNIHR ROADSHOW FOR MEDTECH SMES
MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and
More informationABHI Response to the Kennedy short study on Valuing Innovation
ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.
More informationthe royal society of new zealand: gateway to science and technology strategic priorities
the royal society of new zealand: gateway to science and technology strategic priorities www.royalsociety.org.nz gateway to science and technology in new zealand the royal society of new zealand has operated
More informationCorporate slide master
Corporate slide master Recommendations on Health & Wealth in Wales Ifan Evans Deputy Director Healthcare Innovation Welsh Government 1 What are these recommendations for? The Board s purpose is to: assist
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationHDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018
HDR UK & Digital Innovation Hubs Introduction 22 nd November 2018 Health Data Research UK s vision To create a thriving, high-energy UK-wide network of inter-disciplinary research expertise that will:
More informationHuman factors and design in future health care
Human factors and design in future health care Peter Buckle 1, Simon Walne 1, Simone Borsci 1,2 and Janet Anderson 3 1. NIHR London In Vitro Diagnostics Co-operative, Division of Surgery, Department of
More informationSecurity and Risk Assessment in GDPR: from policy to implementation
Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is
More informationTechnology and Innovation in the NHS Scottish Health Innovations Ltd
Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop
More informationWhere the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
More informationA Science & Innovation Audit for the West Midlands
A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationTHE NUMBERS OPENING SEPTEMBER BE PART OF IT
THE NUMBERS 13million new development dedicated to STEM for Plymouth 5.43million funding from the Heart of the South West Local Enterprise Partnership s Growth Deal 2.7million from the Regional Growth
More informationEnfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results
More informationOxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results
More informationSouthern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results
More informationSouth Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only
CCG 360 o stakeholder survey 2015 Main report 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results Slide 7 Using the results
More informationCCG 360 o stakeholder survey 2017/18
CCG 360 o stakeholder survey 2017/18 Case studies of high performing and improved CCGs 1 Contents 1 Background and key themes 2 3 4 5 6 East and North Hertfordshire CCG: Building on a strong internal foundation
More informationPortsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results
More informationCollaboration Agreement
Collaboration Agreement Central London, West London, Hammersmith & Fulham, Hounslow, Ealing Clinical Commissioning Groups January 2014 Version 5 1 Context In December 2011 the eight North West London (NWL)
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationSutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results
More informationDiffusion of Innovations Theory. 2 nd National Medicine Reconciliation Workshop - 6 September 2011
Diffusion of Innovations Theory 2 nd National Medicine Reconciliation Workshop - 6 September 2011 Diffusion of Innovations (definition) Spread of messages that are perceived as new ideas the process by
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationA manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017
A manifesto for global sustainable health Sustainable Health Symposium Cambridge, UK 25th July 2017 Introduction Across the globe, the health of individuals, their communities and the planet is in crisis
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More information3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey
1. Record Type? 2. Unique Number Reassessment R00423 3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey 4. Collection Type National 5. Other Reference 6. Description CCGs need to have strong relationships
More informationDoing, supporting and using public health research. The Public Health England strategy for research, development and innovation
Doing, supporting and using public health research The Public Health England strategy for research, development and innovation Draft - for consultation only About Public Health England Public Health England
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationTechnology transfer options for low-carbon development
Technology transfer options for low-carbon development Mongi Hamdi Head, Science, Technology and ICT Branch UNCTAD and Head of the CSTD Secretariat UNDP Conference Climate Change and the Road to Rio Algiers,
More informationIFT STRATEGIC PLAN. 2017/18 Strategic Objectives
IFT STRATEGIC PLAN 2017/18 Strategic Objectives STRATEGIC STRUCTURE Feeding Tomorrow Mission IFT Mission IFTSA Mission Strategic Priorities Vision Vision Vision Core Values Strategic Objectives VISION
More informationWe are embarking on a new and exciting phase of dance development in the North West. This is where we get to dream big.
Ambition We are embarking on a new and exciting phase of dance development in the North West. This is where we get to dream big. Who are we? We are anyone involved or connected to dance in the North West
More informationHealth Innovation Manchester
Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing
More information[Definitions of terms that are underlined are found at the end of this document.]
Policy Direction - Pharmaceutical Industry Relationships [Definitions of terms that are underlined are found at the end of this document.] Rationale and Relationship to Mission, Principles and Values The
More informationCatapult Network. Launching your ideas with the UK s new centres for innovation
Catapult Network Launching your ideas with the UK s new centres for innovation The vision What is a Catapult? Hundreds of thousands of businesses in the UK are hungry for growth and capable of bringing
More informationEnfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 360 o stakeholder survey 2014 Summary report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of Clinical
More informationSutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only
CCG 36 o stakeholder survey 214 Summary report Version 1 Internal Use Only 13-98464-1 Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships
More informationGrowing the national institute for data science and artificial intelligence
Growing the national institute for data science and artificial intelligence There has never been a more significant time to work in data science and AI. There is recognition of the importance of these
More informationTechnology and Innovation in the NHS Highlands and Islands Enterprise
Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise
More informationBoard of Directors Non Executive Directors
Board of Directors Non Executive Directors Beatrice Fraenkel Chairman Appointed 1 December 2008, Beatrice s terms ends 3 November 2019. Beatrice is an ergonomist and industrial designer. She is Director
More informationSmart Management for Smart Cities. How to induce strategy building and implementation
Smart Management for Smart Cities How to induce strategy building and implementation Why a smart city strategy? Today cities evolve faster than ever before and allthough each city has a unique setting,
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationSAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services.
SAFEGUARDING ADULTS FRAMEWORK Introduction Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services. Safeguarding adults involves a range of additional
More informationCentre for Healthcare Technologies
Centre for Healthcare Technologies Steve Morgan www.healthcaretechnologies.ac.uk Launched 29.2.16 The future: doom and gloom? 2011 2015 Healthcare Public Patients Clinicians Policy RCUK Regulators NHS
More informationThe case for quality
The case for quality Around the world, up to two billion people lack access to quality essential medicines. Poor-quality medicines undermine the treatment of some of the world s most pressing diseases,
More informationAccountable Officer Report
Accountable Officer Report 1. CCG Annual Report and Annual Public Meeting At its 24 May 2018 meeting, in line with delegated responsibilities, the Audit and Governance Committee approved the CCG s Annual
More informationRESEARCH AND INNOVATION STRATEGY
RESEARCH AND INNOVATION STRATEGY 2015 2020 WELCOME Delivering new opportunities through globally significant research and innovation excellence The Research and Innovation Strategy is the result of significant
More informationQuality by Design, Clinical Relevance & Lifecycle Considerations
Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives
More informationWest Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only
CCG 360 o stakeholder survey 2014 Main report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of health and care
More informationIAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015
IAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015 Clinical Networks Business Planning Parameters for 2015/16 Business Planning Parameters for 2015/16 1. There should be a
More informationKernow CCG CCG 360 o Stakeholder Survey
CCG 360 o Stakeholder Survey 2017-18 Findings 1 Table of contents Slide 3 Summary Slide 6 Introduction Slide 7 Background and objectives Slide 8 Methodology and technical details Slide 10 Interpreting
More informationAuthors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry
Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL
More informationThe Royal College of Radiologists Response to: House of Lords Select Committee on Artificial Intelligence 6 September 2017
Introduction The Royal College of Radiologists Response to: House of Lords Select Committee on Artificial Intelligence 6 September 2017 1. The Royal College of Radiologists (RCR) works with our 10,000
More information2. Evidence themes and their importance along the development path
1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development
More informationInnovation & Knowledge management
Innovation & Knowledge management Lotte Jaspers, Yellow Research 1 My Background From University/medical TTO to start-up to setting up my own company 3 pillar career from Expert to Manager to Expert IPR
More informationVetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018
Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service
More informationA review of the role and costs of clinical commissioning groups
A picture of the National Audit Office logo Report by the Comptroller and Auditor General NHS England A review of the role and costs of clinical commissioning groups HC 1783 SESSION 2017 2019 18 DECEMBER
More informationLed by clinicians, accountable to local people. East Lancashire Clinical Commissioning Group: Equality & Inclusion Annual Report
Clinical Commissioning Group: Equality & Inclusion Annual Report Foreword 3 Introduction and Aims of the Report 4 Commissioning Intentions 4 Our Population 5 Compliance with the Public Sector Equality
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationImagine your future lab. Designed using Virtual Reality and Computer Simulation
Imagine your future lab Designed using Virtual Reality and Computer Simulation Bio At Roche Healthcare Consulting our talented professionals are committed to optimising patient care. Our diverse range
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationWorldSkills UK Construction Roundtable Report: The future of construction is manufacturing June 2018
WorldSkills UK Construction Roundtable Report: The future of construction is manufacturing June 2018 Introduction This roundtable event was conceived out of a need to develop a future-facing perspective
More informationThe Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program
The Future of Patient Data The Global View Key Insights Berlin 18 April 2018 The world s leading open foresight program Context Over a 6 month period, 12 expert discussions have taken place around the
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationJune 12, 2017 Health and the Social Innovation Ecosystem
Waterloo Region June 12, 2017 Health and the Social Innovation Ecosystem Why work on a wellbeing initiative? Community challenges are increasingly complex and therefore need multi-stakeholder approaches.
More informationCCG Improvement and Assessment Framework 2016/17. Briefing Document
CCG Improvement and Assessment Framework 2016/17 Briefing Document 4 th April 2016 Executive Summary NHS England has launched a new Improvement and Assessment Framework for Clinical Commissioning Groups
More informationA Roadmap For Building Indigenous Digital Excellence: Looking To 2030
A Roadmap For Building Indigenous Digital Excellence: Looking To 2030 T: +612 9046 7855 E: info@ncie.org.au idx.org.au Facebook: IndigenousDigitalExcellence Twitter: IndigenousDX 180 George Street Redfern
More informationParkinson s World A transformational project by The Cure Parkinson s Trust
Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication
More informationBefore I talk through the strategy itself, I want to tell you more about why
This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting
More informationDiversity in Science Technology Engineering and Maths (STEM)
1 Diversity in Science Technology Engineering and Maths (STEM) Summary Aim to support UK secure maximum economic and social benefits from its world class research base by increasing STEM skills and diversity
More informationAbout the awards. Categories. Knowledge Transfer Initiative of the Year Knowledge Transfer Achiever of the Year. Judging panel
2015 The KTI Impact Awards recognise successful commercialisation of Irish State-funded research that translates knowledge and expertise for the wider benefit of our economy and society. The awards also
More informationNEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
More informationScottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund
Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell
More informationTriennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence
Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Title: Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Author:
More informationSupporting Innovation through Regulation and Science
Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers
More informationNIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators
NIHR / Wellcome Trust King s Clinical Research Facility Guidance for Investigators Introduction The NIHR Clinical Research Facilities provide dedicated facilities to support the delivery of externally-funded
More informationEastern Cheshire CCG CCG 360 o Stakeholder Survey
CCG 360 o Stakeholder Survey 2017-18 Findings 1 Table of contents Slide 3 Summary Slide 6 Introduction Slide 7 Background and objectives Slide 8 Methodology and technical details Slide 10 Interpreting
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationWHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP?
WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP? Insanity: Doing the same thing over and over again and expecting different results. - Albert Einstein When you come to a fork in the road, take it.
More informationMining Innovation: The Importance of Science Entreprise
1 Mining Innovation: The Importance of Science Entreprise Donna Kirkwood, Ph.D, Geo Deputy Chief Scientist Natural Resources Canada Prepared for the Mining Diesel Emissions Council Conference Toronto October
More information25 th Workshop of the EURORDIS Round Table of Companies (ERTC)
25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00
More informationDigital Health and Introducing Innovative Technologies in the NHS
Digital Health and Introducing Innovative Technologies in the NHS 22 September 2015 NATIONAL INFORMATION BOARD techuk.org @techuk #techuk Digital Health and introducing innovative technologies in the NHS
More informationHow Paediatric Research Networks can help drug development
How Paediatric Research Networks can help drug development Mark Turner An agency of the European Union Why networks? Significant increase in trials and participants Delays are now significant Networks
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationNHS England CCG Authorisation
NHS England CCG Authorisation Post Authorisation December 2013 Review Conditions Report CCG name: Vale of York CCG Wave: 3 Regional Operations Director Jon Develing Date report generated: 22/01/2014 Vale
More informationINTRODUCTION OUR VISION: We are driven to be a preeminent college of pharmacy in the world. Our world begins in Iowa. OUR MISSION:
BRAND GUIDE INTRODUCTION TABLE OF CONTENTS BRAND MESSAGING Introduction.... 1 Core Brand Values... 2 BRAND IDENTITY Logo Usage.... 6 Primary Logo Variations.... 7 Department & Division Logos.... 8 What
More informationForeword. Simon Hunt Managing Director Oxford Policy Management
UK Gender Pay Gap Report 2017-2018 Foreword Equality and inclusivity are at the heart of what we do both in fulfilling our mission and how we act as an employer. We strive to provide an equal platform
More informationDR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND
DR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND EUPHA CONFERENCE, VIENNA 10-12 NOVEMBER 16 @ SCIROCCO_EU 1 SCIROCCO Project EU Health Programme (CHAFEA) EC funding: 1,322, 775
More informationTECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19
TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19 April 2018 Introduction 1. The TEC Board agreed four Strategic Priorities in August 2017 for furthering the development and
More information